Johnson & Johnson: Trouble Behind?

Less than a month ago, I recommended buying shares of Johnson & Johnson (JNJ) after the stock had tumbled more than 3% in one day. At the time, I mentioned that the market seemed worried about the sluggish growth in Johnson & Johnson's pharmaceutical business. Shares of Johnson & Johnson have gained 3.2% since April 22, when I made the call, while the S&P 500 has risen 2.3%.

http://finance.yahoo.com/r/e4c27a64-...ahoo&.tsrc=rss